<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Niox Group Plc — News on 6ix</title>
<link>https://6ix.com/company/niox-group-plc</link>
<description>Latest news and press releases for Niox Group Plc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Fri, 24 Apr 2026 16:20:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/niox-group-plc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d58471beedb30cb6f8b6ac.webp</url>
<title>Niox Group Plc</title>
<link>https://6ix.com/company/niox-group-plc</link>
</image>
<item>
<title>Dividend Timetable</title>
<link>https://6ix.com/company/niox-group-plc/news/dividend-timetable-32</link>
<guid isPermaLink="true">https://6ix.com/company/niox-group-plc/news/dividend-timetable-32</guid>
<pubDate>Fri, 24 Apr 2026 16:20:00 GMT</pubDate>
<description>NIOX Group plc has announced the dividend timetable for its proposed final dividend for the financial year ending 31 December 2025, which is subject to shareholder approval at the Annual General Meeting on 21 May 2026. The dividend per share is set at 1.55 pence, with an ex-dividend date of 21 May 2026, a record date of 22 May 2026, and a payment date of 22 June 2026.
Disclaimer*</description>
</item>
<item>
<title>Director/PDMR Shareholding</title>
<link>https://6ix.com/company/niox-group-plc/news/directorpdmr-shareholding-1151</link>
<guid isPermaLink="true">https://6ix.com/company/niox-group-plc/news/directorpdmr-shareholding-1151</guid>
<pubDate>Tue, 21 Apr 2026 11:18:00 GMT</pubDate>
<description>NIOX Group plc announced that on April 20, 2026, Chief Executive Officer Jonathan Emms sold 69,494 ordinary shares at 57.56 pence each and repurchased 34,542 shares at 57.90 pence, while his spouse purchased 34,539 shares at 57.88 pence. Following these transactions, Jonathan Emms' total shareholding, including his wife's, is 3,658,498 ordinary shares, representing 0.87% of the company's issued share capital.
Disclaimer*</description>
</item>
<item>
<title>Exercise of Options, Director Dealing and TVR</title>
<link>https://6ix.com/company/niox-group-plc/news/exercise-of-options-director-dealing-and-tvr-4</link>
<guid isPermaLink="true">https://6ix.com/company/niox-group-plc/news/exercise-of-options-director-dealing-and-tvr-4</guid>
<pubDate>Fri, 17 Apr 2026 16:59:00 GMT</pubDate>
<description>NIOX Group plc announced that on April 16, 2026, Directors Ian Johnson, Jonathan Emms, and Sarah Duncan exercised share options, resulting in the issuance of 1,466,320 ordinary shares. Subsequently, Jonathan Emms and Sarah Duncan sold a combined 489,885 ordinary shares at 56.4 pence per share to cover tax liabilities and costs. Following these transactions and the exercise of options by other employees, the company's total issued share capital now stands at 420,413,454 ordinary shares.
</description>
</item>
<item>
<title>Grant of Options</title>
<link>https://6ix.com/company/niox-group-plc/news/grant-of-options-209</link>
<guid isPermaLink="true">https://6ix.com/company/niox-group-plc/news/grant-of-options-209</guid>
<pubDate>Thu, 09 Apr 2026 12:55:00 GMT</pubDate>
<description>NIOX Group plc announced the grant of options to Executive Directors over 1,563,605 new ordinary shares under its 2026 Performance Share Plan. The options are exercisable at a nominal value of 0.08p each and will vest on the third anniversary of the grant date, subject to performance conditions including absolute shareholder return and clinical revenue growth over a three-year period. Jonathan Emms received options for 1,060,071 shares, and Sarah Duncan received options for 503,534 shares. These</description>
</item>
<item>
<title>Block Listing Cancellation and Interim Review</title>
<link>https://6ix.com/company/niox-group-plc/news/block-listing-cancellation-and-interim-review</link>
<guid isPermaLink="true">https://6ix.com/company/niox-group-plc/news/block-listing-cancellation-and-interim-review</guid>
<pubDate>Thu, 02 Apr 2026 16:05:00 GMT</pubDate>
<description>NIOX Group plc has announced the cancellation of block listings for several share schemes, including the Circassia 2015 Performance Share Plan Scheme and various NIOX Save As You Earn and Performance Share Plan Schemes, totaling 382,679 ordinary shares. This cancellation is due to the completion of all outstanding options or lapses within these plans. Concurrently, the company provided an interim update on its active block listings, reporting a total of 8,162,838 unallotted securities remaining </description>
</item>
<item>
<title>Director/PDMR Shareholding and Total Voting Rights</title>
<link>https://6ix.com/company/niox-group-plc/news/directorpdmr-shareholding-and-total-voting-rights-23</link>
<guid isPermaLink="true">https://6ix.com/company/niox-group-plc/news/directorpdmr-shareholding-and-total-voting-rights-23</guid>
<pubDate>Wed, 01 Apr 2026 06:00:00 GMT</pubDate>
<description>NIOX Group plc announced that on March 31, 2026, Chief Executive Officer Jonathan Emms was issued 135,188 new ordinary shares valued at 0.08p each under the Deferred Share Bonus Plan, bringing his total holding to 3,399,076 shares, representing a 0.813% interest. This issuance increases the company's total issued share capital to 418,074,453 ordinary shares, each with one voting right, which shareholders should use for disclosure calculations under FCA rules.
Disclaimer*</description>
</item>
<item>
<title>Holding(s) in Company</title>
<link>https://6ix.com/company/niox-group-plc/news/holdings-in-company-1295</link>
<guid isPermaLink="true">https://6ix.com/company/niox-group-plc/news/holdings-in-company-1295</guid>
<pubDate>Tue, 24 Mar 2026 15:22:00 GMT</pubDate>
<description>Artemis Investment Management LLP has notified Niox Group PLC of a change in its major holding, acquiring a 4.14952% stake in the company, representing 17,342,510 voting rights. This acquisition of voting rights occurred on March 23, 2026, and the notification was made on March 24, 2026. The holding is effectively held through Artemis Fund Managers Limited.
Disclaimer*</description>
</item>
<item>
<title>Block Listing Application</title>
<link>https://6ix.com/company/niox-group-plc/news/block-listing-application-163</link>
<guid isPermaLink="true">https://6ix.com/company/niox-group-plc/news/block-listing-application-163</guid>
<pubDate>Mon, 16 Mar 2026 16:30:00 GMT</pubDate>
<description>NIOX Group plc has applied to the London Stock Exchange for a block admission of 4,919,318 ordinary shares, each with a nominal value of 0.08 pence, to be admitted to trading on AIM. These shares will be issued as needed upon the exercise of options under the NIOX 2023 PSP scheme. Admission of these newly listed shares is expected to become effective on 20 March 2026, and they will rank pari passu with existing ordinary shares.
Disclaimer*</description>
</item>
<item>
<title>Total Voting Rights</title>
<link>https://6ix.com/company/niox-group-plc/news/total-voting-rights-955</link>
<guid isPermaLink="true">https://6ix.com/company/niox-group-plc/news/total-voting-rights-955</guid>
<pubDate>Fri, 27 Feb 2026 09:41:00 GMT</pubDate>
<description>NIOX Group plc has announced its total voting rights as of 27 February 2026, confirming 417,939,265 Ordinary Shares in issue, each with one voting right, and no shares held in treasury. This figure has increased due to the exercise of options by employees, resulting in the issuance of 4,937 new Ordinary Shares. These new shares rank pari passu with existing shares and will serve as the denominator for shareholders calculating their notification obligations under the FCA's Disclosure and Transpar</description>
</item>
<item>
<title>Full Year Trading Update</title>
<link>https://6ix.com/company/niox-group-plc/news/full-year-trading-update-90</link>
<guid isPermaLink="true">https://6ix.com/company/niox-group-plc/news/full-year-trading-update-90</guid>
<pubDate>Tue, 20 Jan 2026 07:00:00 GMT</pubDate>
<description>NIOX Group plc reported a strong financial performance for the year ended 31 December 2025, with revenue increasing 17% to approximately £48.7m, driven by a significant 77% surge in research revenue to £10.1m due to increased clinical trial activity. Adjusted EBITDA rose 21% to approximately £16.7m, exceeding market expectations and reflecting operational leverage. The company also successfully launched its new NIOX PRO® device in December 2025 and ended the year with a robust cash balance of £1</description>
</item>
<item>
<title>Replacement: Block Listing Application</title>
<link>https://6ix.com/company/niox-group-plc/news/replacement-block-listing-application-1</link>
<guid isPermaLink="true">https://6ix.com/company/niox-group-plc/news/replacement-block-listing-application-1</guid>
<pubDate>Fri, 16 Jan 2026 08:15:00 GMT</pubDate>
<description>NIOX Group plc has applied to the London Stock Exchange for a block admission of 165,413 ordinary shares of 0.08 pence each to be traded on AIM, expected to become effective on 21 January 2026. These shares will be issued as needed under the Save As You Earn Plan 2023, and upon issuance, they will rank pari passu with existing ordinary shares. This announcement corrects a previous RNS dated 16 January 2026 by removing an incorrectly included adviser.
Disclaimer*</description>
</item>
<item>
<title>Block listing Interim Review</title>
<link>https://6ix.com/company/niox-group-plc/news/block-listing-interim-review-336</link>
<guid isPermaLink="true">https://6ix.com/company/niox-group-plc/news/block-listing-interim-review-336</guid>
<pubDate>Wed, 01 Oct 2025 14:55:00 GMT</pubDate>
<description>NIOX Group PLC has released an interim review regarding its existing block listing arrangements, covering the period from March 31, 2025, to September 30, 2025. The balance of unallotted securities from the previous return totaled 5,368,608. The block schemes increased by 6,862,848 for NIOX 2022 Performance Share Plan Scheme, 1,128,966 for NIOX 2019 Performance Share Plan Scheme, and 78,927 for NIOX 2022 Save As You Earn Scheme (UK). During this period, the number of securities issued/allotted u</description>
</item>
<item>
<title>INTERIM RESULTS</title>
<link>https://6ix.com/company/niox-group-plc/news/interim-results-656</link>
<guid isPermaLink="true">https://6ix.com/company/niox-group-plc/news/interim-results-656</guid>
<pubDate>Tue, 30 Sep 2025 06:00:00 GMT</pubDate>
<description>NIOX Group PLC reported unaudited interim results for the six months ended 30 June 2025, featuring a 20% increase in revenue to £25.2 million. Clinical revenue grew by 8% to £20.0 million, while research revenue surged by 108% to £5.2 million. Adjusted EBITDA increased by 30% to £9.2 million, resulting in an adjusted EBITDA margin of 36.5%. Adjusted basic earnings per share rose by 31% to 2.26p. Cash generated from operations amounted to £7.0 million. The company's cash balance stood at £11.8 mi</description>
</item>
<item>
<title>PDMR/PCA Shareholding</title>
<link>https://6ix.com/company/niox-group-plc/news/pdmrpca-shareholding-8</link>
<guid isPermaLink="true">https://6ix.com/company/niox-group-plc/news/pdmrpca-shareholding-8</guid>
<pubDate>Tue, 22 Jul 2025 12:48:00 GMT</pubDate>
<description>PDMR/PCA Shareholding.</description>
</item>
<item>
<title>Trading Update</title>
<link>https://6ix.com/company/niox-group-plc/news/trading-update-848</link>
<guid isPermaLink="true">https://6ix.com/company/niox-group-plc/news/trading-update-848</guid>
<pubDate>Tue, 08 Jul 2025 06:00:00 GMT</pubDate>
<description>Trading Update.</description>
</item>
<item>
<title>Change of Adviser</title>
<link>https://6ix.com/company/niox-group-plc/news/change-of-adviser-259</link>
<guid isPermaLink="true">https://6ix.com/company/niox-group-plc/news/change-of-adviser-259</guid>
<pubDate>Tue, 27 May 2025 09:00:00 GMT</pubDate>
<description>Change of Adviser.</description>
</item>
<item>
<title>Result of Annual General Meeting</title>
<link>https://6ix.com/company/niox-group-plc/news/result-of-annual-general-meeting-216</link>
<guid isPermaLink="true">https://6ix.com/company/niox-group-plc/news/result-of-annual-general-meeting-216</guid>
<pubDate>Wed, 14 May 2025 14:00:00 GMT</pubDate>
<description>Result of Annual General Meeting.</description>
</item>
<item>
<title>Total Voting Rights Update</title>
<link>https://6ix.com/company/niox-group-plc/news/total-voting-rights-update-3</link>
<guid isPermaLink="true">https://6ix.com/company/niox-group-plc/news/total-voting-rights-update-3</guid>
<pubDate>Thu, 01 May 2025 06:00:00 GMT</pubDate>
<description>Total Voting Rights Update.</description>
</item>
<item>
<title>Dividend Declaration</title>
<link>https://6ix.com/company/niox-group-plc/news/dividend-declaration-485</link>
<guid isPermaLink="true">https://6ix.com/company/niox-group-plc/news/dividend-declaration-485</guid>
<pubDate>Thu, 24 Apr 2025 09:49:00 GMT</pubDate>
<description>Dividend Declaration.</description>
</item>
<item>
<title>Notice of 2025 Annual General Meeting</title>
<link>https://6ix.com/company/niox-group-plc/news/notice-of-2025-annual-general-meeting-15</link>
<guid isPermaLink="true">https://6ix.com/company/niox-group-plc/news/notice-of-2025-annual-general-meeting-15</guid>
<pubDate>Tue, 15 Apr 2025 07:00:00 GMT</pubDate>
<description>Notice of 2025 Annual General Meeting.</description>
</item>
</channel>
</rss>